Xspray Pharma
26,05
SEK
−9,86 %
XSPRAY
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Xspray Pharma is a pharmaceutical company with the goal of improving the quality of life for cancer patients. The company has several product candidates in the clinical development phase and plans to launch its first product on the US market during september 2024. Based on a patented technology for the amorphous formulation of drugs, the company develops product candidates with relevant medical benefits that should be able to be marketed as improved versions of established drugs for the treatment of cancer (protein kinase inhibitors, PKIs).
Lue lisääPörssikalenteri
Osavuosikatsaus Q1'25
Yhtiökokous '25
Osavuosikatsaus Q2'25
Redeye: Xspray Pharma Q4 2024 - In anticipation of an eventful year
Interim Report Fourth Quarter 2024
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.